Alterity Therapeutics Limited (NASDAQ:ATHE – Get Free Report)’s share price rose 17.5% during trading on Wednesday . The stock traded as high as $2.20 and last traded at $1.88. Approximately 343,204 shares were traded during mid-day trading, an increase of 602% from the average daily volume of 48,873 shares. The stock had previously closed at $1.60.
Alterity Therapeutics Price Performance
The company has a 50-day simple moving average of $1.22 and a 200 day simple moving average of $1.49.
About Alterity Therapeutics
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia. The company’s lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson’s disease.
Recommended Stories
- Five stocks we like better than Alterity Therapeutics
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Tesla Poised to Hit Record Highs This Holiday Season
- Most Volatile Stocks, What Investors Need to Know
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is the Shanghai Stock Exchange Composite Index?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Alterity Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alterity Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
